Indications for Digital Monitoring of Patients With Multiple Nevi: Recommendations from the International Dermoscopy Society.

dermatoscopy dermoscopy digital monitoring multiple nevi total body photography

Journal

Dermatology practical & conceptual
ISSN: 2160-9381
Titre abrégé: Dermatol Pract Concept
Pays: Austria
ID NLM: 101585990

Informations de publication

Date de publication:
Nov 2022
Historique:
accepted: 13 01 2022
entrez: 19 12 2022
pubmed: 20 12 2022
medline: 20 12 2022
Statut: epublish

Résumé

In patients with multiple nevi, sequential imaging using total body skin photography (TBSP) coupled with digital dermoscopy (DD) documentation reduces unnecessary excisions and improves the early detection of melanoma. Correct patient selection is essential for optimizing the efficacy of this diagnostic approach. The purpose of the study was to identify, via expert consensus, the best indications for TBSP and DD follow-up. This study was performed on behalf of the International Dermoscopy Society (IDS). We attained consensus by using an e-Delphi methodology. The panel of participants included international experts in dermoscopy. In each Delphi round, experts were asked to select from a list of indications for TBSP and DD. Expert consensus was attained after 3 rounds of Delphi. Participants considered a total nevus count of 60 or more nevi or the presence of a CDKN2A mutation sufficient to refer the patient for digital monitoring. Patients with more than 40 nevi were only considered an indication in case of personal history of melanoma or red hair and/or a MC1R mutation or history of organ transplantation. Our recommendations support clinicians in choosing appropriate follow-up regimens for patients with multiple nevi and in applying the time-consuming procedure of sequential imaging more efficiently. Further studies and real-life data are needed to confirm the usefulness of this list of indications in clinical practice.

Identifiants

pubmed: 36534527
doi: 10.5826/dpc.1204a182
pii: dp1204a182
pmc: PMC9681223
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e2022182

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

©2022 Russo et al.

Déclaration de conflit d'intérêts

Competing interests: None.

Références

Eur J Cancer. 2005 Jan;41(1):45-60
pubmed: 15617990
JAMA Dermatol. 2021 May 1;157(5):521-530
pubmed: 33729464
JAMA Dermatol. 2015 Feb;151(2):178-86
pubmed: 25389712
Br J Dermatol. 2019 Nov;181(5):1009-1016
pubmed: 30820946
JAMA Dermatol. 2016 Mar;152(3):291-8
pubmed: 26536613
Plast Reconstr Surg. 2011 Jul;128(1):305-310
pubmed: 21701348
J Med Genet. 2016 Jan;53(1):1-14
pubmed: 26337759
Curr Dermatol Rep. 2013 Mar 1;2(1):24-34
pubmed: 23580930
J Am Acad Dermatol. 2020 Feb;82(2):398-406
pubmed: 31499156
J Natl Cancer Inst. 2002 Jun 19;94(12):894-903
pubmed: 12072543
Cell Mol Life Sci. 2015 Apr;72(7):1249-60
pubmed: 25433395
Eur J Cancer. 2005 Jan;41(1):28-44
pubmed: 15617989
Int J Cancer. 2008 Jun 15;122(12):2753-60
pubmed: 18366057
J Natl Cancer Inst. 2005 Oct 19;97(20):1507-15
pubmed: 16234564
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1686-95
pubmed: 20570907
Arch Dermatol. 2011 Jul;147(7):790-6
pubmed: 21768478
JAMA Dermatol. 2014 Aug;150(8):819-27
pubmed: 24964862
Int J Epidemiol. 2006 Dec;35(6):1514-21
pubmed: 16943234
Br J Dermatol. 2008 Sep;159(3):669-76
pubmed: 18616769
Eur J Med Chem. 2020 Oct 15;204:112531
pubmed: 32712436
Arch Dermatol. 2010 Mar;146(3):257-64
pubmed: 20231495
J Invest Dermatol. 2000 Jan;114(1):28-33
pubmed: 10620111
Eur J Cancer. 2005 Sep;41(14):2040-59
pubmed: 16125929
Eur J Hum Genet. 2011 Apr;19(4):472-8
pubmed: 21150883
Br J Dermatol. 2015 Jan;172(1):33-47
pubmed: 25204572
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):403-410
pubmed: 32455486
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):972-977
pubmed: 27896853
JAMA Dermatol. 2015 Jun;151(6):607-15
pubmed: 25671687
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Dermatology. 2015;230(4):340-6
pubmed: 25675954
J Clin Oncol. 2017 Jan;35(1):63-71
pubmed: 28034073
Int J Cancer. 2011 Oct 1;129(7):1730-40
pubmed: 21128237
JAMA. 2011 Nov 2;306(17):1891-901
pubmed: 22045767
Clin Lab Med. 2017 Sep;37(3):473-484
pubmed: 28802496
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):247-251
pubmed: 27422807
G Ital Dermatol Venereol. 2017 Jun;152(3):213-223
pubmed: 28121084

Auteurs

Teresa Russo (T)

Dermatology Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.

Vincenzo Piccolo (V)

Dermatology Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.

Elvira Moscarella (E)

Dermatology Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.

Philipp Tschandl (P)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Harald Kittler (H)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

John Paoli (J)

Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Aimilios Lallas (A)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Ralph P Braun (RP)

Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.

Luc Thomas (L)

Department of Dermatology, Lyon-1 University, and Cancer research center Lyon, Lyon, France.

H Peter Soyer (HP)

The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia.

Josep Malvehy (J)

Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Universitat de Barcelona & IDIBAPS & CIBERER, Barcelona, Spain.

Susana Puig (S)

Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Universitat de Barcelona & IDIBAPS & CIBERER, Barcelona, Spain.

Ashfaq Marghoob (A)

Memorial Sloan Kettering Cancer Center, Hauppauge, New York, USA.

Alon Scope (A)

The Kittner Skin Cancer Screening and Research Institute, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Andreas Blum (A)

Public, Private and Teaching Practice of Dermatology, Konstanz, Germany.

Allan C Halpern (AC)

Memorial Sloan Kettering Cancer Center, Hauppauge, New York, USA.

Horacio Cabo (H)

Dermatology Institute of Medical Research, University of Buenos Aires, Buenos Aires, Argentina.

Scott Menzies (S)

Discipline of Dermatology, Sydney Medical School, The University of Sydney and Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW Australia.

Wilhelm Stolz (W)

Department of Dermatology, Allergology, and Environmental Medicine Clinic Thalkirchen, Hospital Munich, Munich, Germany.

Masaru Tanaka (M)

Department of Dermatology, Tokyo Women's Medical University Medical Center East, Japan.

Harold Rabinovitz (H)

Department of Dermatology Medical College of Georgia, Augusta, United States.

Rainer Hofmann-Wellenhof (R)

Department of Dermatology and Venerology, Medical University of Graz, Graz, Austria.

Renato Marchiori Bakos (RM)

Department of Dermatology, Hospital de Clınicas de Porto Alegre - Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Iris Zalaudek (I)

Department of Dermatology, University of Trieste, Trieste, Italy.

Giovanni Pellacani (G)

Department of Dermatology, University of Rome La Sapienza, Rome, Italy.

Ana Varela Veiga (AV)

Department of Dermatology, University Hospital Complex of Ferrol, A Coruña, Spain.

Laura Rosende Maceiras (LR)

Department of Dermatology, University Hospital Complex of Ferrol, A Coruña, Spain.

Cristina de Las Heras-Sotos (C)

Department of Dermatology, University Hospital Complex of Ferrol, A Coruña, Spain.

Giuseppe Argenziano (G)

Dermatology Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.

Classifications MeSH